IDH1 and IDH2 Gene Mutations in Omani Patients with Acute Myeloid Leukemia: Prognostic Significance and Clinic-pathologic Features
Objectives: We sought to define the prevalence of isocitrate dehydrogenase (IDH) mutations, evaluate the clinicopathologic impact of IDH mutations, assess the effect of IDH mutations on the response to the currently offered treatment for acute myeloid leukemia (AML) cases, and determine the impact o...
Main Authors: | Yusra Al Abri, Mohammed Al Huneini, Shoaib Al Zadjali, Mohammed Al Rawahi |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
Oman Medical Specialty Board
2024-01-01
|
סדרה: | Oman Medical Journal |
נושאים: | |
גישה מקוונת: | https://omjournal.org/articleDetails.aspx?coType=1&aId=3718 |
פריטים דומים
-
IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
מאת: Claudio Cerchione, et al.
יצא לאור: (2021-03-01) -
Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah’s Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia
מאת: Ashkan Emadi, et al.
יצא לאור: (2016-03-01) -
Molecular alterations of isocitrate dehydrogenase 1 and 2 (<it>IDH1 </it>and <it>IDH2</it>) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients
מאת: Chotirat Sadudee, et al.
יצא לאור: (2012-03-01) -
IDH1-mutated relapsed or refractory AML: current challenges and future prospects
מאת: Megías-Vericat JE, et al.
יצא לאור: (2019-06-01) -
Impact of IDH Mutations on DNA Methylation of Acute Myeloid Leukemia Related Genes: A Review Article
מאת: Duha M. Bayram, et al.
יצא לאור: (2024-04-01)